Apexigen (APGN) via Brookline Capital Acq (BCAC) deck
Apexigen is a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, with an emphasis on new immuno-oncology agents.
%20via%20Brookline%20Capital%20Acq%20(BCAC)%20deck){kind=link}